Semarang – A medical doctor’s career does not always end in a clinic or lecture hall. This is exemplified by Dr. Widagdo, MSi.Med., MSc., Ph.D., a 2014 alumnus of the Faculty of Medicine Universitas Diponegoro (FK Undip), who is now working as a global leader in drug and vaccine clinical trials within the international pharmaceutical industry.
His academic journey began at FK Undip, where he completed his medical degree. After graduation, he pursued a Master’s degree in Genetic Counseling at FK Undip, followed by a Master’s degree in Immunology and Infectious Diseases in the Netherlands. He later continued his academic career by earning a Ph.D. in Virology from Erasmus University in the Netherlands.
Initially, Dr. Widagdo planned to stay abroad for only two to three years. However, career opportunities and professional growth eventually led him to remain and work in Europe for more than a decade.
Rather than pursuing the lengthy process of medical license equivalency, which can take up to five years in many countries, he chose to build a career in research. After completing his doctoral studies, he undertook postdoctoral research before joining a fellowship program at a global pharmaceutical company with a strong research division.
“I joined their fellowship program, and that marked the beginning of my career in pharmaceutical research,” he said.
Today, Dr. Widagdo is responsible for leading global clinical trials for the development of new medicines and vaccines. In his role, he collaborates with international teams coordinating research across multiple countries to ensure the safety and efficacy of products before they receive regulatory approval. According to him, the education he received at FK Undip provided a strong academic foundation that enabled him to compete on the global stage.
“When it comes to the quality of education, we are not actually behind those abroad. In terms of knowledge and understanding, I have never once felt left behind,” he said.
Nevertheless, he believes that strengthening Indonesia’s research ecosystem remains a significant challenge. While competent human resources are already available, sustained support for research still needs to be improved.
“Research is an investment. The results may not always be visible within one or two years, but they can create a significant impact five to ten years later,” he explained.
For the past seven years, his expertise has focused primarily on vaccines. His background in virology led him to become directly involved in COVID-19 vaccine development when the pandemic emerged. Currently, he serves as Clinical Science Lead, Associate Director at GSK and has been involved in the development of a Respiratory Syncytial Virus (RSV) vaccine that has received regulatory approval and is now used in more than 30 countries for older adults.
Through his experience, Dr. Widagdo has come to appreciate that bringing a new medicine to the public is a long and complex process, beginning with laboratory research, followed by animal studies, multiple phases of clinical trials, and extensive evaluation by international regulatory authorities.
“Bringing a new medicine to the point where it can be used by doctors in clinical practice is extremely demanding. The investment required is substantial, both financially and in terms of time,” he said.
Although he has spent many years working abroad, his desire to contribute to Indonesia remains strong. He continues to share his knowledge through teaching activities at FK Undip whenever opportunities arise.
He believes that many Indonesian graduates possess the capability to pursue similar global career paths. However, he noted that access to information and opportunities remains a challenge that must be expanded.
“I believe many Indonesians are capable of working in positions like mine. It is largely a matter of access, opportunity, and awareness that career paths like this exist,” he said.
To FK Undip students, Dr. Widagdo offered two important messages. First, education is the best investment a person can make. Second, students should not be afraid to pursue a different path, as long as it creates value and is undertaken with dedication.
“The world is vast. Do not think small. If you are not doing the same things as your peers, as long as you are pursuing something you love and contributing positively to those around you, it is still a worthwhile path,” he advised.
At the conclusion of the interview, Dr. Widagdo expressed his gratitude to FK Undip for serving as the foundation of his academic and professional journey. (FK Undip/Saradita/Erman)




